Century Therapeutics, Inc. (IPSC)
1.275
-0.04
(-3.41%)
USD |
NASDAQ |
Oct 07, 16:00
1.34
+0.06
(+5.10%)
After-Hours: 20:00
Century Therapeutics Enterprise Value : 157.28M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 157.28M |
| October 05, 2026 | 186.16M |
| October 02, 2026 | 195.19M |
| October 01, 2026 | 209.64M |
| September 30, 2026 | 227.69M |
| September 29, 2026 | 216.86M |
| September 28, 2026 | 220.47M |
| September 25, 2026 | 220.47M |
| September 24, 2026 | 224.08M |
| September 23, 2026 | 236.72M |
| September 22, 2026 | 260.19M |
| September 21, 2026 | 252.97M |
| September 18, 2026 | 254.77M |
| September 17, 2026 | 258.38M |
| September 16, 2026 | 254.77M |
| September 15, 2026 | 276.44M |
| September 14, 2026 | 280.05M |
| September 11, 2026 | 269.22M |
| September 10, 2026 | 269.22M |
| September 09, 2026 | 285.47M |
| September 08, 2026 | 292.69M |
| September 04, 2026 | 299.91M |
| September 03, 2026 | 296.30M |
| September 02, 2026 | 299.91M |
| September 01, 2026 | 285.47M |
| Date | Value |
|---|---|
| August 31, 2026 | 289.08M |
| August 28, 2026 | 284.56M |
| August 27, 2026 | 321.57M |
| August 26, 2026 | 305.33M |
| August 25, 2026 | 310.74M |
| August 24, 2026 | 301.71M |
| August 21, 2026 | 292.69M |
| August 20, 2026 | 283.66M |
| August 19, 2026 | 299.91M |
| August 18, 2026 | 272.83M |
| August 17, 2026 | 271.02M |
| August 14, 2026 | 265.61M |
| August 13, 2026 | 267.41M |
| August 12, 2026 | 272.83M |
| August 11, 2026 | 290.88M |
| August 10, 2026 | 276.44M |
| August 07, 2026 | 280.05M |
| August 06, 2026 | 261.99M |
| August 05, 2026 | 272.83M |
| August 04, 2026 | 281.85M |
| August 03, 2026 | 276.44M |
| July 31, 2026 | 283.66M |
| July 30, 2026 | 314.35M |
| July 29, 2026 | 283.66M |
| July 28, 2026 | 289.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -56.31M |
| Exicure, Inc. | 5.167M |
| Absci Corp. | 1.565B |
| Celularity, Inc. | 113.82M |
| Cardio Diagnostics Holdings, Inc. | 0.702M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.55M |
| Total Expenses (Quarterly) | 34.55M |
| EPS Diluted (Quarterly) | -0.1679 |
| Earnings Yield | -70.35% |
| Normalized Earnings Yield | -67.04 |